Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 |
filingDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120129927-A |
titleOfInvention |
Modified tuberculous antigen |
abstract |
The present invention relates to modified Rv3616c protein and its use, in particular, as a medicament for preventing reactivation of tuberculosis. |
priorityDate |
2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |